HCA Holdings (HCA) Misses Q4 EPS by 11c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
HCA Healthcare Reports Fourth Quarter 2021 Results and Provides 2022 Guidance
January 27, 2022 7:30 AM ESTCompany Increases Capital Spending, Authorizes Additional Share Repurchase Program and Increases Quarterly Dividend
NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2021.
Key fourth quarter metrics (all percentage changes compare 4Q 2021 to 4Q 2020 unless otherwise noted):
Revenues totaled $15.064 billion Net income attributable to HCA Healthcare, Inc. totaled $1.814 billion, or $5.75 per diluted share Adjusted EBITDA totaled $3.149 billion Cash flows provided by operating activities totaled $2.443... More
